Patents by Inventor Charles B. Carpenter

Charles B. Carpenter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5788968
    Abstract: Disclosed herein are methods for suppressing allograft rejection in mammals comprising administering to a mammal about to undergo or having undergone allograft surgery an agent selected from the group consisting of splenic tissue from an allograft donor, splenic extracts, cultured lymphocytes from an allograft donor, extracts of said cultured lymphocytes, MHC antigens, transplantation rejection suppressive fragments and analogs of MHC antigens in an oral or aerosol form. Also disclosed herein are pharmaceutical formulations and dosage forms for use in said methods.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: August 4, 1998
    Assignee: AutoImmune, Inc.
    Inventors: Howard L. Weiner, David Allen Hafler, Charles B. Carpenter, Mohamed Sayegh, Zhengyi Zhang
  • Patent number: 5681556
    Abstract: Disclosed herein are methods for suppressing allograft rejection in mammals comprising administering to a mammal about to undergo or having undergone allograft surgery an agent selected from the group consisting of splenic tissue from an allograft donor, splenic extracts, cultured lymphocytes from an allograft donor, extracts of said cultured lymphocytes, MHC antigens, transplantation rejection suppressive fragments and analogs of MHC antigens in an oral or aerosol form. Also disclosed herein are pharmaceutical formulations and dosage forms for use in said methods.
    Type: Grant
    Filed: November 29, 1993
    Date of Patent: October 28, 1997
    Assignee: Autoimmune Inc.
    Inventors: Howard L. Weiner, David Allen Hafler, Charles B. Carpenter, Mohamed Sayegh, Zhengyi Zhang
  • Patent number: 5593698
    Abstract: Described are methods for: (a) suppressing the ability of T-cells from a mammal to proliferate in response to stimulation by nonself mammalian tissue; and (b) suppressing immune response which leads to allograft rejection in a mammal receiving an allograft from a donor mammal. The methods involve orally administering to the mammal to be thus treated a composition comprising at least one of: (i) a major histocompatibility complex Class II antigen from a second nonself mammal or from tissue of a mammal syngeneic to said nonself mammal; (ii) at least one synthetic peptide corresponding to a T-cell suppressive fragment of said Class II antigen, said composition being administered in an amount effective to suppress said proliferation. The foregoing compositions are also described.
    Type: Grant
    Filed: March 5, 1993
    Date of Patent: January 14, 1997
    Assignee: Autoimmune, Inc.
    Inventors: Howard L. Weiner, David A. Hafler, Charles B. Carpenter, Mohamed Sayegh, Zhengyi Zhang
  • Patent number: 4730035
    Abstract: Moist halogenated resins separated from an aqueous acid suspension of said resins are dried and stripped of residual acid with a heated inert drying gas. The resins are not washed to lower residual acid or treated with a base compound to neutralize residual acid before drying begins. Inert drying gases include nitrogen, helium, argon and the like. The dried resin has low residual acid and moisture levels. It is white and free of visually detectable areas of discoloration. It also has high thermal stability, particularly when admixed with minor amounts of a thermal stabilizer such as calcium stearate.
    Type: Grant
    Filed: September 4, 1986
    Date of Patent: March 8, 1988
    Assignee: The Dow Chemical Company
    Inventors: Frank E. Mark, Charles B. Carpenter, James B. Akers, Jr.
  • Patent number: 4517289
    Abstract: Immortal, antibody-producing, hybridomally-produced clones which produce antibodies that react specifically with human HLA antigens and which are produced from rat lymphocyte cells sensitized against cells from a rat strain having different histocompatibility antigens are disclosed along with methods of producing the clones and antibodies and methods of using the antibodies in tissue crossing tests.
    Type: Grant
    Filed: August 18, 1982
    Date of Patent: May 14, 1985
    Assignee: Brigham and Women's Hospital
    Inventors: Edgar L. Milford, Charles B. Carpenter, Jean M. Paradysz
  • Patent number: 4418913
    Abstract: The rack permits a single player to play a large number of bingo cards in every game, and without preempting more than his fair share of table space. The rack has a multiplicity of long horizontal rods extending from the player's left to right and supported by a pair of end frames, for instance 4 or 5 such rods, parallel to each other. The rod nearest the player is closest to the table, and is spaced above it a little more than the thickness of two bingo cards. This same spacing is used between rods, i.e., a staircase spacing with the same spacing of the second rod both above and behind the first rod, etc. The bingo cards are mounted in back-to-back pairs in special clips mounted on the rods and pivotal between a vertical position and a horizontal position, reading one card of a pair in each position. Each clip has portions defining a pocket which has an open top and one open side, so that a marginal portion of the pair of bingo cards is received in the pocket.
    Type: Grant
    Filed: April 26, 1982
    Date of Patent: December 6, 1983
    Assignee: Norman L. Hamilton
    Inventors: Norman L. Hamilton, Charles B. Carpenter